Infliximab Biosimilar in Takayasu’s Arteritis
Condition(s):Takayasu ArteritisLast Updated:June 20, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):Takayasu ArteritisLast Updated:June 20, 2017Unknown status
Condition(s):TAKAYASU ARTERITISLast Updated:August 19, 2020Completed
Condition(s):Takayasu’s ArteritisLast Updated:April 12, 2022Recruiting
Condition(s):Takayasu ArteritisLast Updated:August 30, 2023Completed
Condition(s):Takayasu Arteritis (TAK)Last Updated:March 22, 2024Active, not recruiting
Condition(s):Takayasu ArteritisLast Updated:June 28, 2022Recruiting
Condition(s):Takayasu ArteritisLast Updated:March 27, 2012Completed
Condition(s):Takayasu’s ArteritisLast Updated:May 15, 2017Unknown status
Condition(s):Takayasu Arteritis; Anti-Inflammatory AgentsLast Updated:June 8, 2018Unknown status
Condition(s):Takayasu ArteritisLast Updated:October 19, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.